Globus Medical(GMED) ZACKS·2024-11-15 15:51Core Insights - Zacks Premium provides various tools for investors to enhance their stock market engagement and confidence [1] - The Zacks Style Scores are designed to complement the Zacks Rank, helping investors identify stocks with the potential to outperform the market in the short term [3][4] Zacks Style Scores - The Style Scores categorize stocks into four types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [4][5][6] - Value Score identifies undervalued stocks using financial ratios like P/E and Price/Sales [4] - Growth Score assesses stocks based on projected earnings and sales growth [5] - Momentum Score evaluates stocks based on price trends and earnings estimate changes [5] - VGM Score combines all three styles to highlight stocks with the best overall characteristics [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to guide investors in stock selection [7] - Stocks rated 1 (Strong Buy) have historically achieved an average annual return of +25.41%, significantly outperforming the S&P 500 [8] - A total of over 800 stocks are rated 1 or 2, making it essential for investors to utilize Style Scores to refine their choices [9] Stock Highlight: Globus Medical (GMED) - Globus Medical, Inc. is a medical device company focused on solutions for musculoskeletal disorders, operating in 51 countries [11] - GMED holds a 2 (Buy) rating on the Zacks Rank and has a VGM Score of A, indicating strong potential [11] - The stock has shown a 9.7% increase over the past four weeks, supported by upward revisions in earnings estimates for fiscal 2024 [12] - The Zacks Consensus Estimate for GMED has risen by 2.95 per share, with an average earnings surprise of 17.7% [12]